Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06202183

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This research study is a randomized controlled trial that will observe changes in microbiome activity, changes in chemotherapy toxicity, and any changes in treatment outcomes between two groups of participants undergoing chemotherapy with either early-stage or metastatic colorectal cancer. The names of the study groups involved in this study are: * Exercise * Waitlist Control

Detailed description

This research study is a single-center, two-armed, randomized controlled trial that will observe changes in microbiome activity, changes in chemotherapy toxicity, and any changes in treatment outcomes between two groups of participants undergoing chemotherapy with either early-stage or metastatic colorectal cancer. Participants will be randomly assigned to one of two groups: Group A: Exercise group (EXE) vs. Group B: Waitlist control group (WC). Randomization means that a participant will be placed into one of the study groups by chance. The research study procedures include screening for eligibility, blood tests, stool samples, and survey questionnaires. Participation in this research study will last up to 6 months. It is expected that about 84 people will take part in this research study. The American Cancer Society is providing funding for this research study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExercise ProgramA 12 week, home-based, virtually supervised, aerobic and resistance exercise training program comprised of 36 sessions. Participants will be provided with a home stationary bike, resistance bands, and Fitbit. Virtually supervised sessions will be accessible via Zoom platform. For participants who do not have a device, a Wi-Fi-enabled tablet will also be provided.

Timeline

Start date
2024-07-22
Primary completion
2026-07-31
Completion
2027-07-31
First posted
2024-01-11
Last updated
2025-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06202183. Inclusion in this directory is not an endorsement.